Jan Astermark

Professor, Senior Consultant
Department of Hematology Oncology and Radiation Physics, Skane University Hospital, and Institution of Translational Medicine, Lund University, Malmö, Sweden
Malmö, Skane Lan, Sweden

Presentation(s):

• PB0186 - Results from BeneGene-1 Study: Prospective collection of bleeding rate in hemophilia B patients prior to phase 3 study (BeneGene-2) of fidanacogene elaparvovec

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 52.3 - Efficacy and Safety of Fidanacogene Elaparvovec in Adults with Moderately Severe or Severe Hemophilia B: Results from the Phase 3 BENEGENE-2 Gene Therapy Trial

  Tuesday, June 27, 2023
  11:15 – 11:30 ET

• OC 59.3 - Pooled Safety Results from the Multidose explorer Studies of Concizumab in Patients with Haemophilia

  Tuesday, June 27, 2023
  15:15 – 15:30 ET